The trajectory of base editing has been remarkable, progressing from the laboratory to patient care, treating debilitating or ...

Tools like CRISPR-Cas9 are creating new opportunities for innovation in St. Louis, as well as risks around IP protection and regulation.

Adoptive cell therapy (ACT) has emerged as a transformative approach in cancer immunotherapy, with remarkable clinical success in hematological ...

The U.S. Food and Drug Administration approved the first cell-based gene therapies for sickle cell disease, including the ...

The cost of sequencing a human genome has fallen from $100 million in 2001 to around $1,000 today—dropping even faster than Moore’s Law predicted. At the center of this revolution is CRISPR, a ...

I was born in Washington, DC, in 1964, the oldest of three sisters, but the place that truly formed me as a scientist was Hilo, on the Big Island of Hawaii. Growing up there, far from the mainland ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A St. Louis startup is turning ...

Behind every scientific breakthrough at Colossal Biosciences stands a question that transcends technology: Should we? While genetic engineering capabilities have advanced dramatically, the ethical ...

Scientists at St. Jude Children’s Research Hospital report that they have developed an unbiased, sensitive, and resource-efficient method to identify small, off-target sites that pose a safety risk ...

Scientists and physicians can better assess precision genome editing technology using a new method made public today by St. Jude Children's Research Hospital. Significant amounts of time and resources ...